Nippon Kayaku, Eiger deal

Nippon granted Eiger rights to develop Bestatin ubenimex for pulmonary

Read the full 100 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE